Clinical trials
Asthma clinical trials
A condition where the airways narrow and swell, making breathing difficult. We’re tracking 390 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06521229Recruiting
Study of uncontrolled mild to moderate asthma in Russia
This study is for adults with mild to moderate asthma that is not well controlled. Researchers will look at medical records to understand what treatments people are using and what their health is like over time.
AstrakhanAges Any age - NCT07372287RecruitingPhase 3
Study of CM326 for moderate to severe asthma
This trial tests an investigational drug called CM326 for people with moderate to severe asthma that is not well controlled with current treatments. It aims to see if CM326 can help reduce asthma attacks and improve breathing.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07402707RecruitingPhase 4
Dexamethasone for acute asthma in children
This trial tests if a different steroid (dexamethasone) is as good as the usual steroid for treating children with asthma attacks in the Emergency Department. It aims to make treatment easier for children.
SheffieldAges 4–15 - NCT06437444Recruiting
Asthma crisis in children: impact of a new care pathway
This trial looks at how a new care pathway affects children with asthma attacks in emergency rooms, hospitals, and primary care. It aims to improve care for children aged 2 to 14 who have had an asthma flare-up.
Barakaldo, BizkaiaAges Any age - NCT07224061Recruiting
Asthma management program using technology and care coordination
This trial uses a smartphone app and care coordination to help children ages 4–12 with uncontrolled asthma. It aims to improve asthma control and reduce symptoms by connecting clinics and schools.
The Bronx, New YorkAges 4–12 - NCT06902766Recruiting
Digital asthma management for children aged 4 to 12
This trial tests whether a smartphone app and digital inhalers can help monitor and manage asthma in children. It may help parents track treatment better and improve asthma control.
ParisAges 4–12 - NCT07342803RecruitingPhase 2
LP-003 injection for allergic asthma
This trial tests an injection called LP-003 for people with allergic asthma that is not well controlled by current inhalers and other medications. It aims to see if the drug can improve asthma control and reduce flare-ups.
ShanghaiAges 18–75 - NCT07516184Recruiting
Testing a breathing device to diagnose asthma
This study tests a portable handheld device that measures airway function to help diagnose asthma. Researchers want to see if this device can accurately identify asthma in people with breathing symptoms like wheezing and shortness of breath.
BeijingAges 18–75 - NCT06317909Recruiting
New test for airway inflammation after allergen challenge in mild asthma
This study tests a new, non-invasive way to measure airway inflammation after breathing in an allergen (like pollen or dust mite). It is for people with mild asthma that is well controlled with only a rescue inhaler.
Hanover, Lower SaxonyAges 18–65 - NCT06441812RecruitingPhase 2
Long-term safety of a new asthma medicine
This trial tests a new medicine called SHR-1703 for people with eosinophilic asthma (a type of asthma with high levels of certain white blood cells). It looks at how safe the medicine is over time and if it helps control asthma attacks. You must already be using medium or high dose inhaled steroids plus another asthma medicine, and have had at least one asthma attack in the past year.
Chengdu, SichuanAges 18 years+ - NCT07047430Recruiting
Air quality near Sea-Tac airport and children's asthma
This study looks at how air quality near the airport affects children with asthma. Participating families help researchers understand if certain actions can reduce asthma flare-ups.
Seattle, WashingtonAges 6–12 - NCT07134686Recruiting
Combined lung and ear-nose-throat care for asthma and sinusitis
This trial tests if seeing a lung specialist and an ear-nose-throat doctor together in one visit helps people with asthma and chronic sinusitis (with nasal polyps) feel better than seeing each specialist separately. You may qualify if your asthma or sinusitis is not well-controlled and you've used steroid pills in the past year.
MarseilleAges 18 years+ - NCT07666490RecruitingPhase 4
Triple vs double inhaler for uncontrolled asthma
This study compares a three-in-one inhaler (ICS/LABA/LAMA) to a two-in-one inhaler (ICS/LABA) for adults whose asthma is not well-controlled despite using a standard two-in-one inhaler. The goal is to see if the triple inhaler improves asthma control better.
RousseAges 18 years+ - NCT02351141Recruiting
MRI study of lung function in people with asthma
This study uses MRI pictures to learn how asthma affects breathing and lung function. If you have asthma and can do breathing tests, you may be asked to take part to help researchers understand asthma better.
London, OntarioAges 18–60 - NCT07301255RecruitingPhase 2
ENV-294 for moderate-to-severe asthma in adults
This trial tests an experimental drug called ENV-294 in adults with moderate-to-severe asthma. You may join if you are already using two kinds of inhalers regularly and have had at least one asthma flare-up in the past year that needed steroids or a hospital visit.
Birmingham, AlabamaAges 18–75 - NCT07532265RecruitingPhase 2
Testing a New Drug for Hard-to-Control Asthma
This study tests whether a new drug called frevecitinib can help people with severe asthma that isn't well controlled even with strong inhaled steroid medications. The goal is to see if it reduces asthma attacks and improves breathing.
Lancaster, CaliforniaAges 18–75 - NCT03889743RecruitingPhase 4
Steroid treatment to help prevent asthma after a first wheezing illness
This trial studies whether an early steroid treatment can lower the chance that children will go on to develop asthma after their first severe “wheezing” episode caused by a rhinovirus (a common cold virus). If you qualify, the goal is to prevent future asthma rather than just treat the current episode.
TurkuAges 3 months–1.9 years - NCT07713498Enrolling by invitation
Lowering inhaled steroids for tezepelumab-treated asthma patients
This trial looks at whether people with severe asthma who are taking the biologic tezepelumab can safely reduce their use of inhaled corticosteroids (ICS). It aims to see if reducing or stopping ICS affects asthma symptoms or flare-ups.
Rotterdam, South HollandAges 18 years+ - NCT06932263RecruitingPhase 2
Testing tozorakimab for uncontrolled asthma
This trial tests a new drug called tozorakimab for adults whose asthma is not well controlled despite using medium-to-high dose inhaled steroids. The study aims to find the best dose and see if it reduces asthma attacks.
Bakersfield, CaliforniaAges 18–75 - NCT06705764RecruitingPhase 4
Tezepelumab for asthma attacks in the emergency room
This trial tests if a drug called Tezepelumab can help adults with asthma who visit the emergency room. It aims to reduce severe asthma attacks and improve breathing control.
Edmonton, AlbertaAges 18–55 - NCT05757102RecruitingPhase 3
Test new inhaler combo versus standard inhaler in teens
This Phase 3 trial compares a triple inhaler (FF/UMEC/VI) against the usual double inhaler (FF/VI) to help control asthma symptoms and breathing tests in teens ages 12–17. It also checks how safe and tolerable the treatments are over the study period.
Birmingham, AlabamaAges 12–17 - NCT03885245RecruitingPhase 2
L-citrulline supplement for overweight adults with later-onset asthma
This Phase 2 trial tests whether adding L-citrulline can improve asthma control in overweight adults whose asthma started later in life. It compares your asthma symptoms and lung testing results to see if the supplement helps when asthma is already being treated.
Durham, North CarolinaAges 18–65 - NCT03984253Recruiting
Swiss Severe Asthma Register for adults and children
This study set up a long-term asthma registry to better understand people with severe asthma and what treatments they use. If you fit the asthma severity requirements, you may be asked for consent and basic health information so the team can follow your asthma over time.
Liestal, Basel-LandschaftAges 1 year+ - NCT03983603Recruiting
Plant stanols and asthma symptoms prevention
This trial tests whether eating plant stanols (a natural substance found in some foods) can help prevent asthma symptoms in people with stable allergic asthma. You would need to take a daily chew and avoid certain cholesterol-lowering products during the study.
Maastricht, LimburgAges 18–70
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for asthma?
- Yes. Clin2 currently lists 390 recruiting asthma studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a asthma trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a asthma trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.